Incidental Mutation 'G5030:Il1r1'
ID 512
Institutional Source Beutler Lab
Gene Symbol Il1r1
Ensembl Gene ENSMUSG00000026072
Gene Name interleukin 1 receptor, type I
Synonyms IL-iR, IL-1R1, Il1r-1, CD121a, IL-1 receptor alpha chain
Accession Numbers
Essential gene? Probably non essential (E-score: 0.060) question?
Stock # G5030 (G3) of strain 560
Quality Score
Status Validated
Chromosome 1
Chromosomal Location 40264240-40356417 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 40352323 bp (GRCm39)
Zygosity Homozygous
Amino Acid Change Lysine to Glutamic Acid at position 498 (K498E)
Ref Sequence ENSEMBL: ENSMUSP00000110443 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000027241] [ENSMUST00000114795]
AlphaFold P13504
Predicted Effect possibly damaging
Transcript: ENSMUST00000027241
AA Change: K501E

PolyPhen 2 Score 0.477 (Sensitivity: 0.89; Specificity: 0.90)
SMART Domains Protein: ENSMUSP00000027241
Gene: ENSMUSG00000026072
AA Change: K501E

DomainStartEndE-ValueType
signal peptide 1 19 N/A INTRINSIC
IG 38 117 2.94e-1 SMART
IG_like 132 218 5.56e0 SMART
IG 236 333 1.35e0 SMART
Blast:TIR 347 381 1e-7 BLAST
TIR 387 544 1.93e-29 SMART
Predicted Effect possibly damaging
Transcript: ENSMUST00000114795
AA Change: K498E

PolyPhen 2 Score 0.798 (Sensitivity: 0.84; Specificity: 0.93)
SMART Domains Protein: ENSMUSP00000110443
Gene: ENSMUSG00000026072
AA Change: K498E

DomainStartEndE-ValueType
signal peptide 1 16 N/A INTRINSIC
IG 35 114 2.94e-1 SMART
IG_like 129 215 5.56e0 SMART
IG 233 330 1.35e0 SMART
Blast:TIR 344 378 1e-7 BLAST
TIR 384 541 1.93e-29 SMART
Meta Mutation Damage Score 0.0621 question?
Coding Region Coverage
  • 1x: 81.1%
  • 3x: 60.2%
Het Detection Efficiency 35.6%
Validation Efficiency 87% (206/237)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a cytokine receptor that belongs to the interleukin-1 receptor family. The encoded protein is a receptor for interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist. It is an important mediator involved in many cytokine-induced immune and inflammatory responses. This gene is located in a cluster of related cytokine receptor genes on chromosome 2q12. [provided by RefSeq, Dec 2013]
PHENOTYPE: Mice homozygous for a knock-out allele exhibit increased susceptibility to bacterial infection, reduced IL1b responsiveness, delayed tooth eruption, decreased susceptibility to experimental autoimmune uveoritinitis, decreased susceptibility to kidney reperfusion injury, and late onset obesity. [provided by MGI curators]
Allele List at MGI

All alleles(3) : Targeted, knock-out(2) Gene trapped(1)

Other mutations in this stock
Total: 30 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abca8a T A 11: 109,961,165 (GRCm39) I585F probably damaging Het
Adam18 C G 8: 25,141,872 (GRCm39) L232F probably benign Homo
Atp13a4 A G 16: 29,274,306 (GRCm39) I385T probably damaging Homo
Ccdc17 T A 4: 116,455,699 (GRCm39) S277T probably benign Het
Ccng1 A G 11: 40,644,629 (GRCm39) probably benign Het
Ces1f T C 8: 94,000,847 (GRCm39) D99G probably benign Het
Clec16a G A 16: 10,389,425 (GRCm39) R187Q probably damaging Homo
Cryl1 C T 14: 57,579,595 (GRCm39) probably benign Het
Cryzl2 C T 1: 157,292,580 (GRCm39) Q48* probably null Het
Dtx4 A G 19: 12,446,943 (GRCm39) L583P probably benign Het
Ephx4 A T 5: 107,577,693 (GRCm39) D339V probably damaging Het
Eri2 A T 7: 119,385,601 (GRCm39) V300E possibly damaging Het
F3 T A 3: 121,518,648 (GRCm39) N37K probably damaging Homo
Fpr1 A T 17: 18,097,068 (GRCm39) L307H probably damaging Het
Fv1 T A 4: 147,953,618 (GRCm39) N61K possibly damaging Het
Gm5548 T C 3: 112,961,512 (GRCm39) noncoding transcript Homo
Myh11 T C 16: 14,068,443 (GRCm39) I192M probably damaging Homo
Nckap5 T C 1: 125,953,591 (GRCm39) K923R probably damaging Het
Nmbr A T 10: 14,642,747 (GRCm39) Y102F possibly damaging Het
Or6c75 A G 10: 129,337,406 (GRCm39) T218A probably benign Homo
Pde1a C T 2: 79,718,180 (GRCm39) probably benign Het
Pex6 T C 17: 47,026,382 (GRCm39) probably benign Het
Rtn2 T C 7: 19,027,099 (GRCm39) S305P probably damaging Homo
Saal1 G A 7: 46,342,207 (GRCm39) T412I probably damaging Homo
Slc46a2 A T 4: 59,913,867 (GRCm39) I352N probably damaging Het
Trim37 A T 11: 87,033,967 (GRCm39) H99L probably damaging Het
Tubgcp4 C T 2: 121,014,815 (GRCm39) R242C probably damaging Het
Twf2 C A 9: 106,084,141 (GRCm39) L27I possibly damaging Het
Usp40 A T 1: 87,921,941 (GRCm39) H307Q probably damaging Het
Zfhx3 T G 8: 109,678,091 (GRCm39) V3047G possibly damaging Het
Other mutations in Il1r1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01457:Il1r1 APN 1 40,352,330 (GRCm39) missense probably damaging 1.00
IGL01532:Il1r1 APN 1 40,334,088 (GRCm39) critical splice donor site probably null
IGL01610:Il1r1 APN 1 40,341,560 (GRCm39) missense probably benign 0.09
IGL01668:Il1r1 APN 1 40,352,489 (GRCm39) missense probably benign 0.31
IGL01729:Il1r1 APN 1 40,333,986 (GRCm39) missense probably damaging 1.00
IGL02201:Il1r1 APN 1 40,352,428 (GRCm39) missense probably damaging 0.97
IGL02229:Il1r1 APN 1 40,352,518 (GRCm39) missense probably damaging 0.99
IGL02428:Il1r1 APN 1 40,352,392 (GRCm39) missense possibly damaging 0.74
IGL02902:Il1r1 APN 1 40,341,569 (GRCm39) missense probably benign 0.09
R0604:Il1r1 UTSW 1 40,321,406 (GRCm39) missense probably benign 0.36
R1515:Il1r1 UTSW 1 40,332,509 (GRCm39) nonsense probably null
R1530:Il1r1 UTSW 1 40,351,521 (GRCm39) missense probably benign 0.00
R1727:Il1r1 UTSW 1 40,332,424 (GRCm39) missense probably benign 0.16
R1957:Il1r1 UTSW 1 40,352,300 (GRCm39) nonsense probably null
R2163:Il1r1 UTSW 1 40,334,023 (GRCm39) missense probably benign 0.00
R2313:Il1r1 UTSW 1 40,352,470 (GRCm39) missense probably benign 0.19
R4345:Il1r1 UTSW 1 40,337,084 (GRCm39) missense probably benign 0.00
R4622:Il1r1 UTSW 1 40,351,580 (GRCm39) missense probably damaging 0.96
R4735:Il1r1 UTSW 1 40,332,455 (GRCm39) missense probably benign 0.00
R5033:Il1r1 UTSW 1 40,332,684 (GRCm39) missense probably damaging 1.00
R5586:Il1r1 UTSW 1 40,264,411 (GRCm39) start gained probably benign
R6375:Il1r1 UTSW 1 40,334,050 (GRCm39) missense probably damaging 1.00
R6383:Il1r1 UTSW 1 40,352,495 (GRCm39) missense possibly damaging 0.58
R6618:Il1r1 UTSW 1 40,339,971 (GRCm39) missense probably damaging 0.97
R7169:Il1r1 UTSW 1 40,332,519 (GRCm39) critical splice donor site probably null
R7384:Il1r1 UTSW 1 40,321,421 (GRCm39) missense possibly damaging 0.64
R7798:Il1r1 UTSW 1 40,349,526 (GRCm39) missense probably benign
R8040:Il1r1 UTSW 1 40,352,509 (GRCm39) missense probably benign 0.01
R8129:Il1r1 UTSW 1 40,341,447 (GRCm39) missense probably benign 0.04
R9158:Il1r1 UTSW 1 40,332,391 (GRCm39) nonsense probably null
R9643:Il1r1 UTSW 1 40,341,532 (GRCm39) missense probably damaging 1.00
R9723:Il1r1 UTSW 1 40,332,721 (GRCm39) missense probably benign 0.00
R9748:Il1r1 UTSW 1 40,349,496 (GRCm39) missense probably benign
RF007:Il1r1 UTSW 1 40,352,438 (GRCm39) missense probably damaging 1.00
Nature of Mutation

DNA sequencing using the SOLiD technique identified an A to G transition at position 1725 of the Il1r1 transcript using Genbank record NM_008362 in exon 11 of 11 total exons. Two transcripts of the Il1r1 gene are displayed on Ensembl and Vega. The mutated nucleotide causes a lysine to glutamic acid substitution at amino acid 104 of the encoded protein. The mutation has been confirmed by DNA sequencing using the Sanger method (Figure 1).

Protein Function and Prediction

The Il1r1 gene encodes the 576 amino acid receptor for interleukin-1 alpha (IL-1A), beta (IL-1B), and interleukin-1 receptor antagonist protein (IL-1RA). Binding to the agonist leads to the activation of NF-kappaB. Signaling involves formation of a ternary complex containing IL1RAP, TOLLIP, MYD88, and IRAK1 or IRAK2. IL1R1 is a single-pass type I membrane protein that contains  three immunoglobulin (Ig)-like domains at residues 25-115, 121-213 and 229-329, and a cytoplasmic TIR domain at residues 386-544 (Uniprot P13504). Homozygous null mice are grossly normal but fail to respond to IL-1. Mice have decreased skeletal growth.

The K501E change occurs in the TIR domain, but is predicted to be benign by the PolyPhen program (see report). 
Posted On 2010-10-26